Financial Performance - The company's revenue for the third quarter was CNY 314,037,388.30, a decrease of 2.26% compared to the same period last year[3]. - The total profit for the quarter was CNY 63,249,600.62, reflecting a decline of 12.43% year-over-year[3]. - The net profit attributable to shareholders was CNY 55,644,509.97, down 11.44% from the previous year[3]. - Basic earnings per share for the quarter were CNY 0.28, a decrease of 31.71% compared to the same period last year[4]. - Diluted earnings per share also stood at CNY 0.28, reflecting the same percentage decrease[9]. - Net profit for the first three quarters of 2025 was ¥161,838,510.78, a decrease of 7.6% from ¥175,078,443.07 in the first three quarters of 2024[19]. - Basic earnings per share for the first three quarters of 2025 were ¥0.80, down from ¥1.15 in the same period of 2024, a decrease of 30.4%[19]. - The total comprehensive income for the first three quarters of 2025 was ¥161,838,510.78, compared to ¥175,078,443.07 in 2024, a decrease of 7.6%[19]. Research and Development - Research and development expenses totaled CNY 19,129,868.44, representing 6.09% of revenue, an increase of 1.50 percentage points compared to the same period last year[4]. - Research and development expenses increased to ¥53,616,973.15 in 2025, up from ¥46,899,702.71 in 2024, reflecting a growth of 14.5%[17]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,176,023,305.59, an increase of 10.04% from the end of the previous year[4]. - Total assets reached ¥2,176,023,305.59, up from ¥1,977,534,391.32 in the previous year[14]. - The company reported a total non-current asset value of ¥627,624,909.13, compared to ¥457,513,859.59 previously[14]. - Total liabilities rose to ¥562,557,980.03 in 2025, compared to ¥495,076,439.34 in 2024, marking an increase of 13.6%[16]. - The total liabilities include short-term borrowings of ¥39,073,750.00, consistent with the previous period[14]. - The company's total equity increased to ¥1,613,465,325.56 in 2025, up from ¥1,482,457,951.98 in 2024, representing an 8.8% growth[16]. Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 163,249,646.17, a significant increase of 122.98%[8]. - Cash inflow from operating activities for the first three quarters of 2025 was ¥712,782,757.23, compared to ¥637,652,794.73 in 2024, indicating an increase of 11.8%[20]. - The net cash flow from operating activities was $163.25 million, a significant increase from $73.21 million in the previous period, representing a growth of 123.6%[21]. - Cash outflow from investing activities totaled $237.74 million, compared to $102.03 million in the prior period, indicating a 133.3% increase[21]. - The company reported a net cash decrease of $52.74 million, compared to a decrease of $10.01 million in the previous period, indicating a worsening cash position[21]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,383[11]. - The largest shareholder, You Li, holds 32,424,341 shares, representing 16.02% of total shares[11]. Strategic Initiatives - The company is actively involved in strategic partnerships and investments to enhance market presence and product development[12].
先锋精科(688605) - 2025 Q3 - 季度财报